{"id":26543,"date":"2025-06-24T13:51:59","date_gmt":"2025-06-24T11:51:59","guid":{"rendered":"https:\/\/www.clinica-sante.com\/ro\/analize-fara-categorie\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/"},"modified":"2026-02-27T17:50:44","modified_gmt":"2026-02-27T15:50:44","slug":"panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn","status":"publish","type":"product","link":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/","title":{"rendered":"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN"},"content":{"rendered":"<p class=\"ql-align-justify\"><span style=\"color: black;background-color: white\">Testul <\/span><strong style=\"color: black;background-color: white\">Panel 52 gene relevante \u00een tumori solide Oncomine Focus Assay ADN + ARN <\/strong><span style=\"color: black;background-color: white\">este o testare genomic\u0103 de tip multi-biomarker. Reprezint\u0103 un tip de test diagnostic care permite identificarea modific\u0103rilor ADN sau ARN, la nivelul celulelor tumorale. Spre deosebire de testarea genetic\u0103, prin care sunt detectate muta\u021biile mo\u0219tenite, testarea genomic\u0103 se concetreaz\u0103 pe muta\u021biile dob\u00e2ndite, specifice proceselor neoplazice. Procesul evolutiv al tumorilor solide este condus \u00een principal de modific\u0103ri somatice la nivelul unor gene cu rol important \u00een oncogenez\u0103, cunoscute sub denumirea generic\u0103 de gene driver (gene relevante). Identificarea acestor gene, respectiv a muta\u021biilor somatice la nivelul lor (muta\u021bii driver), joac\u0103 un rol crucial \u00een diagnosticarea \u0219i tratamentul personalizat (terapia \u021bintit\u0103) al afec\u021biunilor maligne. <\/span><\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\"><span style=\"color: black;background-color: white\">Identificarea muta\u021biilor la nivelul tumorilor solide ofer\u0103 informa\u021bii despre biologia tumorii, evolu\u021bia acesteia precum \u0219i despre r\u0103spunsul sau rezisten\u021ba la terapie. Ca urmare, testarea genomic\u0103 este esen\u021bial\u0103 pentru stabilirea profilului molecular tumoral \u0219i identificarea biomarkerilor cu poten\u021bial diagnostic, prognostic, predictiv sau preventiv.<\/span><\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\"><span style=\"color: black;background-color: white\">Prin acest test, pot fi analizate 52 de gene relevante \u00een tumorile solide, cu rol important \u00een procesele oncologice \u0219i \u00een ghidarea tratamentului personalizat cu medicamente aprobate FDA.<\/span><\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\">Testul permite analiza concomitent\u0103 a <strong>ADN \u0219i ARN tumoral<\/strong>, cu secven\u021bierea a:<\/p>\n<p class=\"ql-align-justify\">\n<ul>\n<li>35 de gene la nivelul c\u0103rora au loc muta\u021bii \u201e hotspot\u201d,<\/li>\n<li>19 gene asociate cu varia\u021bii ale num\u0103rului de copii (CNV- copy number variation),<\/li>\n<li>23 de gene implicate \u00een evenimente de fuziune genic\u0103.<\/li>\n<\/ul>\n<p class=\"ql-align-justify\">Analiza se realizeaz\u0103 \u00eentr-un singur flux de lucru, ceea ce permite utilizarea unei cantit\u0103\u021bi minime de material biologic (10ng ADN \u0219i 10ng ARN). Astfel, se ob\u021bine o analiz\u0103 precis\u0103 \u0219i fiabil\u0103 a secven\u021belor de acid nucleic provenit dintr-o serie de tipuri de probe tumorale, inclusiv biopsii mici sau aspira\u021bii cu ac fin.\u00a0<\/p>\n<p class=\"ql-align-justify\"><span style=\"color: black;background-color: white\"> <\/span><\/p>\n<p><strong>Afec\u021biuni \u0219i simptome asociate:<\/strong><\/p>\n<\/p>\n<p><span style=\"color: black;background-color: white\">Testarea <\/span><strong style=\"color: black;background-color: white\">Panel 52 gene relevante \u00een tumori solide Oncomine Focus Assay ADN + ARN, <\/strong><span style=\"color: black;background-color: white\">poate fi efectuat\u0103 pentru peste 18 tipuri de tumori solide pentru care exist\u0103 aprobat\u0103 terapie personalizat\u0103 sau sunt disponibile studii clinice. Num\u0103rul de gene relevante pentru fiecare tip de cancer este variabil, conform\u00a0ghidurilor \u00een vigoare \u0219i a studiilor de asociere existente p\u00e2n\u0103 \u00een prezent. <\/span><\/p>\n<\/p>\n<ul>\n<li><strong style=\"color: black;background-color: white\">Cancer de vezic\u0103<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(portocaliu)<\/em><span style=\"color: black;background-color: white\"> \u2013 AKT1, CCND1, EGFR, FGFR1, FGFR3, HRAS, KRAS, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">GIST \u2013 Cancer gastrointestinal<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(gri)<\/em><span style=\"color: black;background-color: white\"> \u2013 BRAF, CCND1, KIT, PDGFRA, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer pancreatic<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(mov)<\/em><span style=\"color: black;background-color: white\"> \u2013 CDK6, CTNNB1, FGFR1, KRAS, MYC.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer de s\u00e2n<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(roz)<\/em><span style=\"color: black;background-color: white\"> \u2013 AKT1, CCND1, EREBB2, FGFR1, MYC, NTRK3, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer de cap \u0219i g\u00e2t<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(alb cu mov)<\/em><span style=\"color: black;background-color: white\"> \u2013 CCND1, CDK6, EGFR, ERBB2, FGFR1, FGFR2, HRAS, KRAS, MET, NRAS, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer de prostat\u0103<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(bleu)<\/em><span style=\"color: black;background-color: white\"> \u2013 AR, BRAF, ERG, ETV1, ETV4, ETV5, FGFR1, HRAS, IDH1, KRAS, MYC, RAF1.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer de colon<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(albastru)<\/em><span style=\"color: black;background-color: white\"> \u2013 KRAS, NRAS, HRAS, BRAF, PIK3CA, AKT1.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer pulmonar<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(alb)<\/em><span style=\"color: black;background-color: white\"> \u2013 EGFR, BRAF, MET, RET, ERBB2, KRAS, ALK, ROS, NTRK.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Carcinom bazocelular<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(gri \u00eenchis)<\/em><span style=\"color: black;background-color: white\"> \u2013 CTNNB1, HRAS, KRAS, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer endometrial<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(violet)<\/em><span style=\"color: black;background-color: white\"> \u2013 AKT1, CCND1, CTNNB1, ERBB2, ESR1, FGFR1, FGFR2, KRAS, NRAS, MYC, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer hepatic<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(verde)<\/em><span style=\"color: black;background-color: white\"> \u2013 BRAF, CCND1, CTNNB1, IDH1, IDH2, KRAS, MYC, NRAS.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Sarcom de \u021besut moale<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(galben)<\/em><span style=\"color: black;background-color: white\"> \u2013 CCND1, CDK4, ERG, FGFR1, HRAS, KRAS, NRAS, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer esofagian<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(violet)<\/em><span style=\"color: black;background-color: white\"> \u2013 CCND1, CDK6, CTNNB1, FGFR2, KRAS, MAP2K1, MYC, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Melanom<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(gri intermediar)<\/em><span style=\"color: black;background-color: white\"> \u2013 BRAF, CCND1, CDK4, GNA11, GNAQ, IDH1, KRAS, MAP2K1, MYC, NRAS.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer testicular<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(mov)<\/em><span style=\"color: black;background-color: white\"> \u2013 BRAF, CTNNB1, FGFR3, HRAS, KIT, KRAS, NRAS.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer gastric<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(lila pal)<\/em><span style=\"color: black;background-color: white\"> \u2013 AR, BRAF, CCND1, MYC, CDK4, EGFR, ERBB, FGFR2, KRAS, MET, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer ovarian<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(violet)<\/em><span style=\"color: black;background-color: white\"> \u2013 BRAF, CCND1, CTNNB1, FGFR1, KIT, KRAS, MYCN, PIK3CA.<\/span><\/li>\n<li><strong style=\"color: black;background-color: white\">Cancer tiroidian<\/strong><span style=\"color: black;background-color: white\"> <\/span><em style=\"color: black;background-color: white\">(fund\u0103 tricolor\u0103: verde sus, roz mijloc, mov jos)<\/em><span style=\"color: black;background-color: white\"> \u2013 AKT, BRAF, CTNNB1, HRAS, IDH1, KRAS, NRAS, NTRK1, RET.<\/span><\/li>\n<\/ul>\n<p class=\"ql-align-justify\"><strong style=\"color: black;background-color: white\">Simptomele cancerului<\/strong><span style=\"color: black;background-color: white\">\u00a0variaz\u0103 \u00een func\u021bie de tipul \u0219i localizarea acestuia, dar pot <\/span><strong style=\"color: black;background-color: white\">include sc\u0103dere inexplicabil\u0103 \u00een greutate, oboseal\u0103 persistent\u0103 care nu dispare odat\u0103 cu odihna, durere inexplicabil\u0103 care nu dispare pe o perioad\u0103 lung\u0103, modific\u0103ri ale pielii, noduli sau umfl\u0103turi, s\u00e2nger\u0103ri anormale, febr\u0103 persistent\u0103 sau infec\u021bii frecvente, tuse sau r\u0103gu\u0219eal\u0103 persistent\u0103 \u0219i modific\u0103ri ale obiceiurilor intestinale sau urinare<\/strong><span style=\"color: black;background-color: white\">.\u00a0Prezen\u021ba acestor simptome nu \u00eenseamn\u0103 obligatoriu cancer, dar impune consultarea unui medic pentru investiga\u021bii.\u00a0<\/span><\/p>\n<p class=\"ql-align-justify\">\n<p><strong>Cui se adreseaz\u0103 analiza<\/strong><\/p>\n<\/p>\n<ul>\n<li>Pacien\u021bilor oncologici, de ambele sexe,diagnostica\u021bi cu diferite tipuri de tumori solide, \u00een stadiu local avansat sau metastazat, pentru care exist\u0103 aprobat\u0103 FDA\/EMA &#8211; o terapie \u021bintit\u0103, conform ghidurilor \u00een vigoare (NCCN, ESMO, ASCO).<\/li>\n<\/ul>\n<ul>\n<li>Pacien\u021bilor oncologici cu rezultat negativ pentru o testare \u021bintit\u0103 (ex. Melanom BRAF negativ), \u00een vederea extinderii analizei genetice pentru identificarea subtipului molecular \u0219i a personaliz\u0103rii terapiei pacientului oncologic.<\/li>\n<\/ul>\n<p class=\"ql-align-justify\"><strong>Metodologie de testare<\/strong><\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\">Testul presupune extrac\u021bia acizilor nucleici din \u021besut inclus \u00een parafin\u0103 \u0219i analiza acestora prin <strong>\u00a0<\/strong>secven\u021biere de genera\u021bie urm\u0103toare (NGS &#8211; Next Generation Sequencing).<\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\"><strong>Beneficii \u0219i importan\u021b\u0103 clinic\u0103<\/strong><\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\">Testarea NGS a devenit o prioritate \u00een oncologia de precizie pentru orientarea tratamentului personalizat sau pentru includerea pacientului oncologic \u00een studii clinice. Un num\u0103r tot mai mare de alter\u0103ri genomice influenteaz\u0103 deciziile de tratament at\u00e2t pentru tumorile primare c\u00e2t \u0219i pentru cele secundare.<\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\">Acest test ofer\u0103:<\/p>\n<p class=\"ql-align-justify\">\n<ul>\n<li>testare comprehensiv\u0103 &#8211; eliminarea utiliz\u0103rii de tehnologii multiple, \u00een cascad\u0103 (FISH, IHC, PCR, Real-Time PCR);<\/li>\n<li>\u00a0rezultat complex \u00een timp relativ scurt, utiliz\u00e2nd o cantitate minim\u0103 de material biologic;<\/li>\n<li>posibilitate de evaluare simultan\u0103 a unui num\u0103r mare de biomarkeri, oferind multiple op\u021biuni de tratament, altele dec\u00e2t terapia standard de \u00eengrijire, cu importan\u021b\u0103 terapeutic\u0103 \u00een 18 tipuri de tumori solide;<\/li>\n<li>\u00a0analiz\u0103 concomitent\u0103 a ADN \u015fi ARN extras din aceea\u015fi prob\u0103 de \u021besut inclus \u00een parafin\u0103 (FFPE) utiliz\u00e2nd o cantitate redus\u0103 de material biologic (2-3 sec\u021biuni de \u021besut inclus \u00een parafin\u0103), ceea ce permite chiar \u015fi analiza probelor cu material tisular redus (biopsii ob\u021binute prin FNA &#8211; fine-needle aspiration);<\/li>\n<li>analiza a peste 1000 de variante patologice \u00een 52 de gene driver cum ar fi <em>EGFR, BRAF<\/em>, <em>KRAS, ERBB2<\/em> \u0219i <em>MET<\/em>, precum \u0219i fusiuni care implic\u0103 genele <em>ALK, ROS1, RET, NTRK1\/2\/3<\/em>, etc;<\/li>\n<li>identificarea op\u021biunilor de tratament, compatibile cu profilul tumoral molecular, cu eligibilitate pentru tratament personalizat \u00een multiple tipuri de cancer, c\u00e2t \u0219i identificarea de noi \u021binte terapeutice, \u00eentr-un timp relativ scurt;<\/li>\n<li>conform Na\u021bional Cancer Institute (martie 2025), pentru 31 de tipuri de cancere &#8211; inclusiv pentru cele 18 testate prin acest panel- a fost aprobat un num\u0103r cuprins \u00eentre 4 \u015fi 39 de medicamente (inhibitori tirozin kinazici sau anticorpi monoclonali), \u00een func\u021bie de tipul de cancer. De exemplu:\u00a0pentru cancerul de prostat\u0103 \u015fi cel de piele (melanom \u015fi carcinom bazocelular), sunt aprobate c\u00e2te 20 de medicamente; pentru cel pancreatic &#8211; 7; pentru cel tiroidian \u2013 8; iar pentru tumori solide cu diverse localiz\u0103ri &#8211; 9;<\/li>\n<li>ob\u021binerea de indica\u021bii timpurii despre rezisten\u021ba la tratament,\u00a0evit\u00e2nd astfel expunerea non-responderilor la toxicitatea unui tratament f\u0103r\u0103 beneficiu terapeutic;<\/li>\n<li>eliberarea unui rezultat care include \u0219i un raport Oncomine, generat cu acces la baza de date ClinVar, \u00een care sunt prezentate informa\u021bii despre:\n<ul>\n<li>variantele cu semnifica\u021bie clinic\u0103 detectate, \u00a0\u00a0\u00a0\u00a0<\/li>\n<li>poten\u021bialul impact terapeutic (sau absen\u021ba acestuia),<\/li>\n<li>terapiile \u021bintite eligibile, \u00a0\u00a0\u00a0\u00a0\u00a0<\/li>\n<li>trialurile clinice disponibile la momentul actual.<\/li>\n<\/ul>\n<\/li>\n<li>detec\u021bie simultan\u0103 de: muta\u021bii hotspot (SNV, InDel) la nivelul a 35 de gene: <em>AKT1, ALK, AR, BRAF, CDK4, CTNNB1, DDR2, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR2, FGFR3, GNA11, GNAQ, HRAS, IDH1, IDH2, JAK1, JAK2, JAK3, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, NRAS, PDGFRA, PIK3CA, RAF1, RET, ROS1, SMO;<\/em><\/li>\n<li>CNV la nivelul a 19 gene: <em>ALK, AR, BRAF, CCND1, CDK4, CDK6, EGFR, ERBB2, FGFR1, FGFR2, FGFR3, FGFR4, KIT, KRAS, MET, MYC, MYCN, PDGFRA, PIK3CA<\/em>;<\/li>\n<li>fuziuni genice &#8211; implic\u0103 23 de gene: <em>ABL1, AKT3, ALK, AXL, BRAF, EGFR, ERBB2, ERG, ETV1, ETV4, ETV5, FGFR1, FGFR2, FGFR3, MET, NTRK1, NTRK2, NTRK3, PDGFRA, PPARG, RAF1, RET, ROS1,<\/em><em style=\"color: #ff9900\"> <\/em><strong style=\"color: #ff9900\"><u>fiecare dintre aceste variante reprezent\u00e2nd \u021binte terapeutice pentru diferite medicamente oncologice aprobate FDA.<\/u><\/strong><\/li>\n<\/ul>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\">Ghidarea tratamentului anti-tumoral, pe baza caracteriz\u0103rii profilului molecular, prin secven\u021bierea ADN \u0219i ARN tumoral, ofer\u0103 pacien\u021bilor:<\/p>\n<p class=\"ql-align-justify\">\n<ul>\n<li>acces la terapia \u021bintit\u0103- rate mai mari de supravie\u021buire f\u0103r\u0103 cancer (remisii);<\/li>\n<li>rate crescute de supravie\u021buire f\u0103r\u0103 progresie (progression free survival) ;<\/li>\n<li>efecte secundare reduse;<\/li>\n<li>stare de s\u0103n\u0103tate general\u0103 mai bun\u0103;<\/li>\n<li>posibilitatea de \u00eenrolare in trialuri clinice.<\/li>\n<\/ul>\n<p class=\"ql-align-justify\"><strong>Particularit\u0103\u021bi \u0219i limit\u0103ri<\/strong><\/p>\n<p class=\"ql-align-justify\">\n<ul>\n<li>Tehnica utilizat\u0103 are o specificitate \u0219i o sensibilitate superioare tehnicilor clasice (IHC, Real-Time PCR, FISH);<\/li>\n<li>Utilizarea unui panel targeted-NGS nu ridic\u0103 probleme de interpretare a patogenit\u0103\u021bii variantelor identificate \u015fi, implicit , pentru evaluarea riscului, spre deosebire de panelurile NGS extinse\u00a0(&gt;400 gene).<\/li>\n<li>Probele de calitate redus\u0103 (material tisular insuficient, procent tumoral &lt;20%, concentra\u021bie ADN \u0219i\/sau ARN &lt; 10 ng, ADN degradat\/denaturat ca urmare a proceselor de includere \u00een parafin\u0103), pot prezenta date NGS de calitate inferioar\u0103, improprii gener\u0103rii unui rezultat precis;<\/li>\n<li>Variantele identificate cu o acoperire extrem de sc\u0103zut\u0103 sunt considerate artefacte, fiind excluse din analiza bioinformatic\u0103 a datelor.<\/li>\n<\/ul>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\"><strong>Tip prob\u0103<\/strong>: \u021besut \u00een parafin\u0103 (bloc FFPE)<\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\"><strong>Recoltare \u0219i condi\u021bii<\/strong><\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\">Testul se realizeaz\u0103 pe sec\u021biuni de \u021besut inclus \u00een parafin\u0103 (FFPE),\u00een general cu grosimea de 5 microni,\u0219i etalate pe lama microscopic\u0103, f\u0103r\u0103 a fi colorate prin colora\u021bia clasic\u0103 cu hematoxilin-eozin\u0103.<\/p>\n<p class=\"ql-align-justify\">Medicul anatomo-patolog indic\u0103 o zon\u0103 cu celularitate tumoral\u0103 crescut\u0103, cu zone de necroz\u0103, fibroz\u0103 sau infiltrat inflamator \u00een cantit\u0103ti c\u00e2t mai reduse,de unde se va efectua simultan extrac\u021bia de ADN \u0219i ARN. Testarea genetic\u0103 pentru detec\u021bia diferitelor tipuride modific\u0103ri geneticede la nivelul celor 52 de gene se realizeaz\u0103 prin metoda NGS.<\/p>\n<p class=\"ql-align-justify\">\n<p>Pentru interpretarea rezultatelor de genetic\u0103, te po\u021bi adresa speciali\u0219tilor no\u0219tri. Ei te pot ghida \u0219i \u00ee\u021bi pot oferi informa\u021bii suplimentare despre testele genetice din oferta noastr\u0103. Consultul genetic se poate programa at\u00e2t \u00eenainte, c\u00e2t \u0219i dup\u0103 efectuarea testului. Acesta din urm\u0103 este <strong>GRATUIT<\/strong> \u0219i este destinat interpret\u0103rii rezultatelor \u0219i stabilirii indica\u021biilor terapeutice.<\/p>\n<\/p>\n<p><strong>\u00a0E-mail: <a href=\"mailto:consult.genetic@clinica-sante.ro\" rel=\"noopener noreferrer\" target=\"_blank\">consult.genetic@clinica-sante.ro<\/a><\/strong><\/p>\n<\/p>\n<p><strong>\u00a0Telefon: <\/strong>0773.975.894 ( Luni-Vineri \u00een intervalul orar 8.00-16.30 )<\/p>\n<\/p>\n<p class=\"ql-align-justify\"><strong> Call Center: *8787\u00a0<\/strong><\/p>\n<p class=\"ql-align-justify\">\n<\/p>\n<\/p>\n<p class=\"ql-align-justify\">\n","protected":false},"excerpt":{"rendered":"<p class=\"ql-align-justify\"><span style=\"background-color: white;color: black\">Acest panel testeaz\u0103 peste 1000 variante genetice (SNP, in\/del, CNV, fuziuni) \u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \u0219i ARN, \u00een vederea orient\u0103rii tratamentului personalizat. <\/span><\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\"><span style=\"background-color: white;color: black\">Rezultatele testului au <\/span><strong style=\"background-color: white;color: black\">relevan\u021b\u0103 \u00een stabilirea eligibilit\u0103\u021bii pentru terapia \u021bintit\u0103<\/strong><span style=\"background-color: white;color: black\"> sau pentru includerea \u00een studii clinice disponibile \u00een prezent <\/span><strong style=\"background-color: white;color: black\">pentru 18 tipuri de<\/strong><span style=\"background-color: white;color: black\"> <\/span><strong style=\"background-color: white;color: black\">tumori solide<\/strong><span style=\"background-color: white;color: black\">. <\/span><\/p>\n<p class=\"ql-align-justify\">\n<p class=\"ql-align-justify\"><span style=\"background-color: white;color: black\">Astfel, testul ofer\u0103 <\/span><strong style=\"background-color: white;color: black\">\u0219ansa unui<\/strong><span style=\"background-color: white;color: black\"> <\/span><strong style=\"background-color: white;color: black\">tratament genetic personalizat pentru tumori solide<\/strong><span style=\"background-color: white;color: black\">, <\/span><strong style=\"background-color: white;color: black\">aprobat de FDA \u0219i realizat conform ghidurilor medicale actuale<\/strong><span style=\"background-color: white;color: black\">.<\/span><\/p><\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"product_brand":[],"product_cat":[1209,3165,2876],"product_tag":[],"class_list":["post-26543","product","type-product","status-publish","product_cat-analize","product_cat-oncogenetica","product_cat-serviciu-laborator","first","instock","sale","virtual","purchasable","product-type-simple"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"Acest panel testeaz\u0103 peste 1000 variante genetice (SNP, in\/del, CNV, fuziuni) \u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \u0219i ARN, \u00een vederea orient\u0103rii tratamentului personalizat. Rezultatele testului au relevan\u021b\u0103 \u00een stabilirea eligibilit\u0103\u021bii pentru terapia \u021bintit\u0103 sau pentru includerea \u00een studii clinice disponibile \u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\u0103 \u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \u0219i realizat conform ghidurilor medicale actuale.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 4.9.9\" \/>\n\t\t<meta property=\"og:locale\" content=\"ro_RO\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Clinica Sante - Laborator de Analize Medicale - Clinica Sante - Laborator de Analize Medicale\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN - Clinica Sante - Laborator de Analize Medicale\" \/>\n\t\t<meta property=\"og:description\" content=\"Acest panel testeaz\u0103 peste 1000 variante genetice (SNP, in\/del, CNV, fuziuni) \u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \u0219i ARN, \u00een vederea orient\u0103rii tratamentului personalizat. Rezultatele testului au relevan\u021b\u0103 \u00een stabilirea eligibilit\u0103\u021bii pentru terapia \u021bintit\u0103 sau pentru includerea \u00een studii clinice disponibile \u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\u0103 \u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \u0219i realizat conform ghidurilor medicale actuale.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-06-24T11:51:59+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-02-27T15:50:44+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN - Clinica Sante - Laborator de Analize Medicale\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Acest panel testeaz\u0103 peste 1000 variante genetice (SNP, in\/del, CNV, fuziuni) \u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \u0219i ARN, \u00een vederea orient\u0103rii tratamentului personalizat. Rezultatele testului au relevan\u021b\u0103 \u00een stabilirea eligibilit\u0103\u021bii pentru terapia \u021bintit\u0103 sau pentru includerea \u00een studii clinice disponibile \u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\u0103 \u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \u0219i realizat conform ghidurilor medicale actuale.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro#listItem\",\"position\":1,\"name\":\"Prima pagin\\u0103\",\"item\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-medicale\\\/#listItem\",\"name\":\"Analize Medicale\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-medicale\\\/#listItem\",\"position\":2,\"name\":\"Analize Medicale\",\"item\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-medicale\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize\\\/#listItem\",\"name\":\"Analize\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro#listItem\",\"name\":\"Prima pagin\\u0103\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize\\\/#listItem\",\"position\":3,\"name\":\"Analize\",\"item\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-serviciu-laborator\\\/#listItem\",\"name\":\"Serviciu laborator\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-medicale\\\/#listItem\",\"name\":\"Analize Medicale\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-serviciu-laborator\\\/#listItem\",\"position\":4,\"name\":\"Serviciu laborator\",\"item\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-serviciu-laborator\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/#listItem\",\"name\":\"Oncogenetica\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize\\\/#listItem\",\"name\":\"Analize\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/#listItem\",\"position\":5,\"name\":\"Oncogenetica\",\"item\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/#listItem\",\"name\":\"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-serviciu-laborator\\\/#listItem\",\"name\":\"Serviciu laborator\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/#listItem\",\"position\":6,\"name\":\"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/#listItem\",\"name\":\"Oncogenetica\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/#organization\",\"name\":\"Clinica Sante - Laborator de Analize Medicale\",\"description\":\"Clinica Sante - Laborator de Analize Medicale Clinica Sante - Laborator de Analize Medicale - Clinica Sante - Laborator de Analize Medicale\",\"url\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/\",\"telephone\":\"+40376448099\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Necesar-website-nou-CS-Romania_Logo-1024x1024-1.png\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/#organizationLogo\",\"width\":1024,\"height\":1024},\"image\":{\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/#organizationLogo\"}},{\"@type\":\"Product\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/#wooCommerceProduct\",\"name\":\"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN\",\"description\":\"Acest panel testeaz\\u0103 peste 1000 variante genetice (SNP, in\\\/del, CNV, fuziuni) \\u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \\u0219i ARN, \\u00een vederea orient\\u0103rii tratamentului personalizat. Rezultatele testului au relevan\\u021b\\u0103 \\u00een stabilirea eligibilit\\u0103\\u021bii pentru terapia \\u021bintit\\u0103 sau pentru includerea \\u00een studii clinice disponibile \\u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\\u0103 \\u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \\u0219i realizat conform ghidurilor medicale actuale.\",\"url\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/\",\"sku\":\"9046\",\"offers\":{\"@type\":\"Offer\",\"url\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/#wooCommerceOffer\",\"price\":5016,\"priceCurrency\":\"RON\",\"category\":\"Analize\",\"availability\":\"https:\\\/\\\/schema.org\\\/InStock\",\"priceSpecification\":{\"@type\":\"PriceSpecification\",\"price\":5016,\"priceCurrency\":\"RON\"},\"seller\":{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/#organization\"}}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/#webpage\",\"url\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/\",\"name\":\"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN - Clinica Sante - Laborator de Analize Medicale\",\"description\":\"Acest panel testeaz\\u0103 peste 1000 variante genetice (SNP, in\\\/del, CNV, fuziuni) \\u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \\u0219i ARN, \\u00een vederea orient\\u0103rii tratamentului personalizat. Rezultatele testului au relevan\\u021b\\u0103 \\u00een stabilirea eligibilit\\u0103\\u021bii pentru terapia \\u021bintit\\u0103 sau pentru includerea \\u00een studii clinice disponibile \\u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\\u0103 \\u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \\u0219i realizat conform ghidurilor medicale actuale.\",\"inLanguage\":\"ro-RO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/analize-oncogenetica\\\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\\\/#breadcrumblist\"},\"datePublished\":\"2025-06-24T13:51:59+03:00\",\"dateModified\":\"2026-02-27T17:50:44+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/#website\",\"url\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/\",\"name\":\"Clinica Sante - Laborator de Analize Medicale\",\"alternateName\":\"CLINICA SANTE ROMANIA\",\"description\":\"Clinica Sante - Laborator de Analize Medicale\",\"inLanguage\":\"ro-RO\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.clinica-sante.com\\\/ro\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN - Clinica Sante - Laborator de Analize Medicale<\/title>\n\n","aioseo_head_json":{"title":"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN - Clinica Sante - Laborator de Analize Medicale","description":"Acest panel testeaz\u0103 peste 1000 variante genetice (SNP, in\/del, CNV, fuziuni) \u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \u0219i ARN, \u00een vederea orient\u0103rii tratamentului personalizat. Rezultatele testului au relevan\u021b\u0103 \u00een stabilirea eligibilit\u0103\u021bii pentru terapia \u021bintit\u0103 sau pentru includerea \u00een studii clinice disponibile \u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\u0103 \u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \u0219i realizat conform ghidurilor medicale actuale.","canonical_url":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro#listItem","position":1,"name":"Prima pagin\u0103","item":"https:\/\/www.clinica-sante.com\/ro","nextItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-medicale\/#listItem","name":"Analize Medicale"}},{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-medicale\/#listItem","position":2,"name":"Analize Medicale","item":"https:\/\/www.clinica-sante.com\/ro\/analize-medicale\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize\/#listItem","name":"Analize"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro#listItem","name":"Prima pagin\u0103"}},{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize\/#listItem","position":3,"name":"Analize","item":"https:\/\/www.clinica-sante.com\/ro\/analize\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-serviciu-laborator\/#listItem","name":"Serviciu laborator"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-medicale\/#listItem","name":"Analize Medicale"}},{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-serviciu-laborator\/#listItem","position":4,"name":"Serviciu laborator","item":"https:\/\/www.clinica-sante.com\/ro\/analize-serviciu-laborator\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/#listItem","name":"Oncogenetica"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize\/#listItem","name":"Analize"}},{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/#listItem","position":5,"name":"Oncogenetica","item":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/#listItem","name":"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-serviciu-laborator\/#listItem","name":"Serviciu laborator"}},{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/#listItem","position":6,"name":"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN","previousItem":{"@type":"ListItem","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/#listItem","name":"Oncogenetica"}}]},{"@type":"Organization","@id":"https:\/\/www.clinica-sante.com\/ro\/#organization","name":"Clinica Sante - Laborator de Analize Medicale","description":"Clinica Sante - Laborator de Analize Medicale Clinica Sante - Laborator de Analize Medicale - Clinica Sante - Laborator de Analize Medicale","url":"https:\/\/www.clinica-sante.com\/ro\/","telephone":"+40376448099","logo":{"@type":"ImageObject","url":"https:\/\/www.clinica-sante.com\/ro\/wp-content\/uploads\/2024\/04\/Necesar-website-nou-CS-Romania_Logo-1024x1024-1.png","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/#organizationLogo","width":1024,"height":1024},"image":{"@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/#organizationLogo"}},{"@type":"Product","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/#wooCommerceProduct","name":"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN","description":"Acest panel testeaz\u0103 peste 1000 variante genetice (SNP, in\/del, CNV, fuziuni) \u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \u0219i ARN, \u00een vederea orient\u0103rii tratamentului personalizat. Rezultatele testului au relevan\u021b\u0103 \u00een stabilirea eligibilit\u0103\u021bii pentru terapia \u021bintit\u0103 sau pentru includerea \u00een studii clinice disponibile \u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\u0103 \u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \u0219i realizat conform ghidurilor medicale actuale.","url":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/","sku":"9046","offers":{"@type":"Offer","url":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/#wooCommerceOffer","price":5016,"priceCurrency":"RON","category":"Analize","availability":"https:\/\/schema.org\/InStock","priceSpecification":{"@type":"PriceSpecification","price":5016,"priceCurrency":"RON"},"seller":{"@type":"Organization","@id":"https:\/\/www.clinica-sante.com\/ro\/#organization"}}},{"@type":"WebPage","@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/#webpage","url":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/","name":"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN - Clinica Sante - Laborator de Analize Medicale","description":"Acest panel testeaz\u0103 peste 1000 variante genetice (SNP, in\/del, CNV, fuziuni) \u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \u0219i ARN, \u00een vederea orient\u0103rii tratamentului personalizat. Rezultatele testului au relevan\u021b\u0103 \u00een stabilirea eligibilit\u0103\u021bii pentru terapia \u021bintit\u0103 sau pentru includerea \u00een studii clinice disponibile \u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\u0103 \u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \u0219i realizat conform ghidurilor medicale actuale.","inLanguage":"ro-RO","isPartOf":{"@id":"https:\/\/www.clinica-sante.com\/ro\/#website"},"breadcrumb":{"@id":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/#breadcrumblist"},"datePublished":"2025-06-24T13:51:59+03:00","dateModified":"2026-02-27T17:50:44+03:00"},{"@type":"WebSite","@id":"https:\/\/www.clinica-sante.com\/ro\/#website","url":"https:\/\/www.clinica-sante.com\/ro\/","name":"Clinica Sante - Laborator de Analize Medicale","alternateName":"CLINICA SANTE ROMANIA","description":"Clinica Sante - Laborator de Analize Medicale","inLanguage":"ro-RO","publisher":{"@id":"https:\/\/www.clinica-sante.com\/ro\/#organization"}}]},"og:locale":"ro_RO","og:site_name":"Clinica Sante - Laborator de Analize Medicale - Clinica Sante - Laborator de Analize Medicale","og:type":"article","og:title":"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN - Clinica Sante - Laborator de Analize Medicale","og:description":"Acest panel testeaz\u0103 peste 1000 variante genetice (SNP, in\/del, CNV, fuziuni) \u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \u0219i ARN, \u00een vederea orient\u0103rii tratamentului personalizat. Rezultatele testului au relevan\u021b\u0103 \u00een stabilirea eligibilit\u0103\u021bii pentru terapia \u021bintit\u0103 sau pentru includerea \u00een studii clinice disponibile \u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\u0103 \u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \u0219i realizat conform ghidurilor medicale actuale.","og:url":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/","article:published_time":"2025-06-24T11:51:59+00:00","article:modified_time":"2026-02-27T15:50:44+00:00","twitter:card":"summary_large_image","twitter:title":"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN - Clinica Sante - Laborator de Analize Medicale","twitter:description":"Acest panel testeaz\u0103 peste 1000 variante genetice (SNP, in\/del, CNV, fuziuni) \u00een 52 de gene relevante (driver) pentru tumorile solide, la nivel de ADN \u0219i ARN, \u00een vederea orient\u0103rii tratamentului personalizat. Rezultatele testului au relevan\u021b\u0103 \u00een stabilirea eligibilit\u0103\u021bii pentru terapia \u021bintit\u0103 sau pentru includerea \u00een studii clinice disponibile \u00een prezent pentru 18 tipuri de tumori solide. Astfel, testul ofer\u0103 \u0219ansa unui tratament genetic personalizat pentru tumori solide, aprobat de FDA \u0219i realizat conform ghidurilor medicale actuale."},"aioseo_meta_data":{"post_id":"26543","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"seo_analyzer_scan_date":"2026-02-27 16:25:00","breadcrumb_settings":null,"limit_modified_date":false,"open_ai":null,"ai":null,"created":"2025-06-24 12:21:35","updated":"2026-02-27 16:28:38"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.clinica-sante.com\/ro\" title=\"Prima pagin\u0103\">Prima pagin\u0103<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.clinica-sante.com\/ro\/analize-medicale\/\" title=\"Analize Medicale\">Analize Medicale<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.clinica-sante.com\/ro\/analize\/\" title=\"Analize\">Analize<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.clinica-sante.com\/ro\/analize-serviciu-laborator\/\" title=\"Serviciu laborator\">Serviciu laborator<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/\" title=\"Oncogenetica\">Oncogenetica<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tPanel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Prima pagin\u0103","link":"https:\/\/www.clinica-sante.com\/ro"},{"label":"Analize Medicale","link":"https:\/\/www.clinica-sante.com\/ro\/analize-medicale\/"},{"label":"Analize","link":"https:\/\/www.clinica-sante.com\/ro\/analize\/"},{"label":"Serviciu laborator","link":"https:\/\/www.clinica-sante.com\/ro\/analize-serviciu-laborator\/"},{"label":"Oncogenetica","link":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/"},{"label":"Panel 52 gene relevante in tumori solide Oncomine Focus Assay ADN + ARN","link":"https:\/\/www.clinica-sante.com\/ro\/analize-oncogenetica\/panel-52-gene-relevante-in-tumori-solide-oncomine-focus-assay-adn-arn\/"}],"_links":{"self":[{"href":"https:\/\/www.clinica-sante.com\/ro\/wp-json\/wp\/v2\/product\/26543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.clinica-sante.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.clinica-sante.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"wp:attachment":[{"href":"https:\/\/www.clinica-sante.com\/ro\/wp-json\/wp\/v2\/media?parent=26543"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.clinica-sante.com\/ro\/wp-json\/wp\/v2\/product_brand?post=26543"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.clinica-sante.com\/ro\/wp-json\/wp\/v2\/product_cat?post=26543"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.clinica-sante.com\/ro\/wp-json\/wp\/v2\/product_tag?post=26543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}